ELMD
Electromed Inc.

727
Mkt Cap
$210.26M
Volume
35,541.00
52W High
$35.56
52W Low
$17.73
PE Ratio
27.12
ELMD Fundamentals
Price
$25.10
Prev Close
$25.21
Open
$25.55
50D MA
$24.60
Beta
0.55
Avg. Volume
38,728.09
EPS (Annual)
$0.8455
P/B
4.71
Rev/Employee
$355,555.56
Loading...
Loading...
News
all
press releases
Best Momentum Stock to Buy for Nov. 17th
ROKU, NRIM and ELMD made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2025.
Zacks·3d ago
News Placeholder
More News
News Placeholder
Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
Electromed (ELMD) could produce exceptional returns because of its solid growth attributes.
Zacks·6d ago
News Placeholder
Electromed (ELMD) Upgraded to Buy: Here's Why
Electromed (ELMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·6d ago
News Placeholder
Wall Street Analysts Think Electromed (ELMD) Could Surge 39.17%: Read This Before Placing a Bet
The consensus price target hints at a 39.2% upside potential for Electromed (ELMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·6d ago
News Placeholder
Electromed, Inc. (ELMD) Surpasses Q1 Earnings and Revenue Estimates
Electromed (ELMD) delivered earnings and revenue surprises of +13.64% and +1.30%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·8d ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +50.00% and -13.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·9d ago
News Placeholder
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of +14.29% and +1.83%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago
News Placeholder
OPKO Health (OPK) Q3 Earnings Surpass Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of +250.00% and -3.44%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·22d ago
News Placeholder
Zacks.com featured highlights include Red Robin Gourmet Burgers, 10x Genomics, Norwegian Cruise Line, Electromed and Analog Devices
Zacks spotlights five efficient stocks Red Robin, 10x Genomics, Norwegian Cruise Line, Electromed, and Analog Devices that excel in turning assets and operations into profits.
Zacks·1mo ago
News Placeholder
5 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
From Red Robin to Analog Devices, these five high-efficiency stocks stand out for their strong ratios and surprise earnings potential.
Zacks·1mo ago

Latest ELMD News

View

Advertisement|Remove ads.

Advertisement|Remove ads.